Atezolizumab
Showing 1 - 25 of 570
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +10 more
- Atezolizumab and Recombinant Human Hyaluronidase
- Survey Administration
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jul 14, 2022
Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)
Not yet recruiting
- Endometrial Cancer
- Metastasis
- Atezolizumab
- ONC201
- (no location specified)
Sep 12, 2022
Hepatocellular Carcinoma Trial (Ezurpimtrostat, Atezolizumab, Bevacizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- Ezurpimtrostat
- +2 more
- (no location specified)
Jul 4, 2022
Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Atezolizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 23, 2022
Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)
Not yet recruiting
- Stage II Melanoma
- Atezolizumab
- +2 more
-
Duarte, California
- +5 more
Jun 6, 2022
Head and Neck Tumors, MSI-H Cancer, Melanoma Trial (Tiragolumab and atezolizumab)
Not yet recruiting
- Head and Neck Neoplasms
- +2 more
- Tiragolumab and atezolizumab
- (no location specified)
Aug 1, 2022
Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))
Active, not recruiting
- Breast Cancer
- Atezolizumab
- Stereotactic radiosurgery (SRS)
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 15, 2022
Glioblastoma Multiforme Trial (Atezolizumab + FSRT radiation)
Not yet recruiting
- Glioblastoma Multiforme
- Atezolizumab + FSRT radiation
- (no location specified)
Jun 14, 2022
Hepatocellular Carcinoma Trial in Tampa (Selinexor Pill, Bevacizumab, Atezolizumab)
Recruiting
- Hepatocellular Carcinoma
- Selinexor Pill
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Aug 16, 2022
Intrahepatic Cholangiocarcinoma Trial in Bad Saarow (Atezolizumab, Derazantinib)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Atezolizumab
- Derazantinib
-
Bad Saarow, GermanyHELIOS KLinikum Bad Saarow
Jun 2, 2022
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
Recruiting
- Small Cell Lung Cancer
- atezolizumab
-
Chalon-sur-Saône, France
- +1 more
Jun 29, 2022
Hepatocellular Carcinoma, Cancer of Liver Trial (PXS-5505 and Atezolizumab and Bevacizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- Cancer of Liver
- PXS-5505 and Atezolizumab and Bevacizumab
- (no location specified)
Jul 11, 2022
Cutaneous Melanoma Trial in Houston (Atezolizumab)
Recruiting
- Cutaneous Melanoma
- Atezolizumab
-
Houston, TexasHouston Methodist Hospital
Dec 28, 2021
Urothelial Cancer Trial (Atezolizumab, RO7247669, Tiragolumab)
Not yet recruiting
- Urothelial Cancer
- Atezolizumab
- +2 more
- (no location specified)
Dec 21, 2022
Hepatocellular Carcinoma Trial (SBRT + atezolizumab and bevacizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- SBRT + atezolizumab and bevacizumab
- (no location specified)
Aug 3, 2022
Sarcoma,Soft Tissue Trial in France (Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery, 2 cycles of
Recruiting
- Sarcoma,Soft Tissue
- Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery
- +2 more
-
Bordeaux, France
- +4 more
Mar 28, 2022
Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)
Not yet recruiting
- Solid Tumor
- Atezolizumab
- +3 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Mar 29, 2022
Hepatocellular Carcinoma, Resectable Hepatocellular Carcinoma Trial in Boston (Atezolizumab, Bevacizumab, Stereotactic Beam
Recruiting
- Hepatocellular Carcinoma
- Resectable Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 10, 2022
Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)
Not yet recruiting
- Cholangiocarcinoma
- Liver Cancer
- Infigratinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)
Recruiting
- Refractory Solid Tumor
- +4 more
- Atezolizumab
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 4, 2022
Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)
Active, not recruiting
- Triple Negative Breast Cancer
- Atezolizumab
- +4 more
-
London, United KingdomBarts Health NHS Trust
Aug 10, 2022
Extensive-stage Small Cell Lung Cancer Trial in Changsha (Radiation Therapy)
Completed
- Extensive-stage Small Cell Lung Cancer
- Radiation Therapy
-
Changsha, Hunan, China
- +1 more
Jun 10, 2022